HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Susan B Laffan Selected Research

Congenital Abnormalities (Deformity)

10/2006Artesunate-induced depletion of embryonic erythroblasts precedes embryolethality and teratogenicity in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Susan B Laffan Research Topics

Disease

1Body Weight (Weight, Body)
11/2022
1Gonorrhea
11/2022
1Joint Diseases (Joint Disease)
11/2022
1Urinary Tract Infections (Urinary Tract Infection)
11/2022
1Immune Complex Diseases (Immune Complex Disease)
01/2020
1Inflammation (Inflammations)
01/2020
1Melanoma (Melanoma, Malignant)
12/2015
1Congenital Abnormalities (Deformity)
10/2006
1Necrosis
10/2006

Drug/Important Bio-Agent (IBA)

1Topoisomerase InhibitorsIBA
11/2022
1FluoroquinolonesIBA
11/2022
1gepotidacinIBA
11/2022
1Antigen-Antibody Complex (Immune Complex)IBA
01/2020
1Complement System Proteins (Complement)IBA
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1AntibodiesIBA
01/2020
1dabrafenibIBA
12/2015
1Proto-Oncogene Proteins B-rafIBA
12/2015
1artemisinin (artemisinine)IBA
10/2006
1ArtesunateIBA
10/2006
1Antimalarials (Antimalarial Agents)IBA
10/2006

Therapy/Procedure

1Intravenous Injections
01/2020
1Aftercare (After-Treatment)
10/2006